Biotech Equity Research: Tracking The Promise (And Risk) Of Early Stage Companies Navigating The Public Markets

Posted on September 24, 2024

October 3, 2024, 3:00 – 4:00 p.m. EST

Benjamin J. Burnett, PhD, Managing Director, Equity Research,
Stifel Investment Services

Register in advance – after registering you will receive Zoom confirmation: https://upstate.zoom.us/meeting/register/tJMoceyqrj4uG9KSdZelOnSJ3toAA4TSwc4P

Ben Burnett, Biotech Equity Research Analyst at Stifel will discuss the intersection of early stage life science companies and finance. We plan to cover recent capital market trends and forecasts, timing the market, and what it takes to become (and be) a public company. Balancing innovation with capital needs requires a good understanding of how and when to access capital, and whether or not this is more easily done as a private or public company. We plan to delve into these concepts in detail and walk through informative case studies of both success and failure.

Benjamin Burnett, PhD, joined Stifel in March of 2018.  Based in Syracuse, NY, Dr. Burnett is a Managing Director, Equity Analyst in the Healthcare sector covering Biotechnology stocks. Dr. Burnett was previously an Associate Vice President working on the team of Paul Matteis covering small-cap and mid-cap biotechnology companies at Stifel. Prior to coming to Stifel, he held a similar role on Mr. Matteis’s team at Leerink focusing primarily on biotechnology stocks. Before starting at Leerink, Dr. Burnett earned a PhD in Biophysics at Cornell University’s medical college (Weill) where he studied the kinetics of protein synthesis and, in particular, the role that G-proteins play in this process.

Other Network News

logo
November 18, 2026

ARCO Helps SupplyOne Evaluate Facility Needs for National Expansion

The project supports SupplyOne’s continued growth by consolidating key warehouse, office, and production functions into a manufacturing environment designed around the company’s operational needs.

Christopher Andreucci
November 18, 2026

Member News: Harris Beach Murtha Names New CEO

Harris Beach Murtha Names Christopher A. Andreucci New CEO

Cornell Cooperative Extension Tree Syrup Workshop
November 16, 2026

Cornell Cooperative Extension Tree Syrup Workshop

This program will provide an overview of the different types of trees that can be tapped for syrup.

Alex Levi portrait photo
November 13, 2026

Lifetime Benefit Solutions Names Alex Levi President

Lifetime Benefit Solutions (LBS) has named Alex Levi president, effective Oct. 3, 2026.

The Lodge at Turning Stone Honored with Prestigious 2027 Condé Nast Johansens Award for ExcellenceThe Lodge at Turning Stone’s exceptional standard for hospitality, fine dining and restorative wellness spotlighted in the recognition
November 12, 2026

The Lodge at Turning Stone Honored with Prestigious 2027 Condé Nast Johansens Award for Excellence

The Lodge at Turning Stone’s exceptional standard for hospitality, fine dining and restorative wellness spotlighted in the recognition.

Oswego YMCA's 35th Annual Reindeer Run 5K Run/WalkDash into the holiday spirit! Join us for the Oswego YMCA’s 35th Annual Reindeer Run 5K Run/Walk on Saturday, December 5 at 9:30am!
November 6, 2026

Oswego YMCA's 35th Annual Reindeer Run 5K Run/Walk

All ages and abilities are welcome to enjoy this festive community tradition filled with fitness, fun and holiday cheer!

November 5, 2026

Harris Beach Murtha Recognized in 2027 Edition of Best Law Firms

Best Lawyers® has released the 2027 Best Law Firms rankings in which Harris Beach Murtha was recognized nationally and regionally.

November 5, 2026

Seminar: Your Product Is Great. Too Bad Nobody Will Pay for It.

The speaker will discuss the process and timing of product reimbursement during a startup’s strategic planning and the importance of implementing a reimbursement plan.

Tenbit Emiru
November 4, 2026

Excellus BlueCross BlueShield Names Dr. Tenbit Emiru Chief Medical Officer

Tenbit Emiru, MD, PhD, MBA has joined Excellus BCBS and its parent company, The Lifetime Healthcare Companies, as enterprise chief medical officer and senior vice president of medical services.